Iterum Therapeutics

$1.70
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.11 (-6.29%) Today
+$0.06 (+3.66%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ITRM and other stocks, options, and ETFs commission-free!

About ITRM

Iterum Therapeutics plc Ordinary Share, also called Iterum Therapeutics, is a pharmaceutical company, which engages in the development and commercialization of sulopenem to be potentially the first and only oral and intravenous (IV) branded penem available. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland. The listed name for ITRM is Iterum Therapeutics plc Ordinary Share.

CEO
Corey N. Fishman
Employees
44
Headquarters
Dublin, Dublin
Founded
2015
Market Cap
268.70M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
31.49M
High Today
$1.75
Low Today
$1.55
Open Price
$1.71
Volume
15.23M
52 Week High
$6.02
52 Week Low
$0.451

ITRM Earnings

-$2.15
-$1.43
-$0.72
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 11, Pre-Market

You May Also Like

LTRPB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure